AngioDynamics (ANGO) Tops Q1 EPS by 4c, Revenues Miss; Offers FY20 EPS Guidance Below Consensus, FY20 Mid-Point Revenue View Above Consensus
Tweet Send to a Friend
AngioDynamics (NASDAQ: ANGO) reported Q1 EPS of $0.08, $0.04 better than the analyst estimate of $0.04. Revenue for the quarter ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
